NZ731850A - System and method for preventing alopecia - Google Patents
System and method for preventing alopeciaInfo
- Publication number
- NZ731850A NZ731850A NZ731850A NZ73185015A NZ731850A NZ 731850 A NZ731850 A NZ 731850A NZ 731850 A NZ731850 A NZ 731850A NZ 73185015 A NZ73185015 A NZ 73185015A NZ 731850 A NZ731850 A NZ 731850A
- Authority
- NZ
- New Zealand
- Prior art keywords
- hair
- agonists
- alpha
- disorders
- limitation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462080137P | 2014-11-14 | 2014-11-14 | |
| US201562099830P | 2015-01-05 | 2015-01-05 | |
| US201562213355P | 2015-09-02 | 2015-09-02 | |
| US201562221863P | 2015-09-22 | 2015-09-22 | |
| PCT/US2015/060663 WO2016077744A1 (en) | 2014-11-14 | 2015-11-13 | System and method for preventing alopecia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ731850A true NZ731850A (en) | 2023-06-30 |
Family
ID=55955138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ731850A NZ731850A (en) | 2014-11-14 | 2015-11-13 | System and method for preventing alopecia |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US10238593B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3217967B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6829196B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102476626B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN107427479B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015346126B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112017009980A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2967375C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2761688T3 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ731850A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016077744A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112017009980A2 (pt) | 2014-11-14 | 2018-02-14 | Follea Int | ?sistema e método para prevenção de alopecia?. |
| WO2016201286A1 (en) | 2015-06-11 | 2016-12-15 | Applied Biology, Inc. | Treatment of sexual dysfunction |
| KR102493627B1 (ko) * | 2015-11-26 | 2023-01-31 | 코웨이 주식회사 | 호르데닌을 유효성분으로 함유하는 피부암 예방 또는 치료용 약학 조성물 |
| WO2018093370A1 (en) * | 2016-11-17 | 2018-05-24 | Follea International | System and method for preventing alopecia |
| EP3426276B1 (en) | 2017-05-24 | 2024-01-24 | Follea International | Synephrine compositions |
| WO2019143857A1 (en) * | 2018-01-17 | 2019-07-25 | University Of Florida Research Foundation, Incorporated | Betel quid cessation therapy with nicotine and pilocarpine |
| WO2020023084A1 (en) * | 2018-07-26 | 2020-01-30 | Applied Biology, Inc. | Taar receptor agonists for the treatment of alopecia |
| CN115135294A (zh) * | 2020-02-19 | 2022-09-30 | 株式会社资生堂 | 利用立毛肌细胞激活的老化改善方法 |
| WO2024118094A1 (en) * | 2022-11-29 | 2024-06-06 | Follea International | System and method for preventing alopecia |
| CN121190403B (zh) * | 2025-09-05 | 2026-04-07 | 北京大学第三医院(北京大学第三临床医学院) | 一种基于人工智能的雄激素性秃发检测方法及系统 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4034109A (en) | 1973-01-18 | 1977-07-05 | Wilkinson Sword Limited | Compounds having a physiological cooling effect and compositions containing them |
| US4853216A (en) * | 1987-04-02 | 1989-08-01 | Bristol-Myers Company | Process and composition for the topical application of alpha1 adrenergic agonist for pilomotor effects |
| US5055456A (en) * | 1989-01-27 | 1991-10-08 | American Cyanamid Co. | Anti-alopecia composition |
| WO1994023748A1 (en) | 1993-04-08 | 1994-10-27 | The University Of Queensland | Administration of vaso-active agent and therapeutic agent |
| CA2154979A1 (en) | 1995-07-28 | 1997-01-29 | Kenneth T. Armstrong | Topical phenylephrine preparation |
| US6294517B1 (en) | 1996-02-02 | 2001-09-25 | Nitromed, Inc. | Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use |
| US5922341A (en) | 1997-10-28 | 1999-07-13 | Vivus, Incorporated | Local administration of pharmacologically active agents to treat premature ejaculation |
| US6747008B1 (en) * | 2000-06-19 | 2004-06-08 | University Of Southern California | Methods for treating and preventing alopecia |
| US20040198706A1 (en) | 2003-03-11 | 2004-10-07 | Carrara Dario Norberto R. | Methods and formulations for transdermal or transmucosal application of active agents |
| GB0225908D0 (en) | 2002-11-06 | 2002-12-11 | Pfizer Ltd | Treatment of female sexual dysfunction |
| US20140011774A1 (en) * | 2002-12-05 | 2014-01-09 | University Of Tennessee Research Foundation | Selective androgen receptor modulators |
| US6938624B2 (en) * | 2003-01-30 | 2005-09-06 | Hairlocs, Inc. | Methods and devices for applying hair extensions |
| US20060252734A1 (en) | 2004-09-08 | 2006-11-09 | Woodward John R | Methods of female sexual enhancement |
| EP1807087A2 (en) | 2004-10-12 | 2007-07-18 | Ernir Snorrason | Inhibitors of acetylcholinesterase for treating skin diseases |
| US20060110415A1 (en) | 2004-11-22 | 2006-05-25 | Bioderm Research | Topical Delivery System for Cosmetic and Pharmaceutical Agents |
| PT2656860T (pt) * | 2005-06-17 | 2021-07-28 | Wisconsin Alumni Res Found | Preparações vasoconstritoras tópicas e métodos para proteção de células durante a quimoterapia e a radioterapia do cancro |
| US7533676B2 (en) * | 2005-07-11 | 2009-05-19 | Aderans Holdings Co., Ltd. | Do-it yourself removable/reusable non-chemical highlights and hair extensions |
| EP1790343A1 (en) | 2005-11-11 | 2007-05-30 | Emotional Brain B.V. | Pharmaceuticals formulations and uses thereof in the treatment of female sexual dysfunction |
| US20090068287A1 (en) | 2007-09-12 | 2009-03-12 | Susan Welsh | Novel topical formulations of flucytosine and uses thereof |
| PT2818184T (pt) * | 2007-11-16 | 2019-01-28 | Aclaris Therapeutics Inc | Composições e métodos para o tratamento de púrpura |
| CN102573848A (zh) | 2009-04-24 | 2012-07-11 | 济州大学校产学协力团 | 含有去甲加兰他敏化合物作为活性成分的用于预防和治疗脱发症的组合物 |
| US9084891B2 (en) | 2012-02-06 | 2015-07-21 | David Aberizk | Pilomotor effect stimulating device and method |
| JP2016047806A (ja) * | 2014-08-28 | 2016-04-07 | 一丸ファルコス株式会社 | フェニルエチルアミン誘導体又はシネフリン含有アデノシン三リン酸フォスファターゼ発現誘導剤 |
| BR112017009980A2 (pt) | 2014-11-14 | 2018-02-14 | Follea Int | ?sistema e método para prevenção de alopecia?. |
| WO2016201286A1 (en) | 2015-06-11 | 2016-12-15 | Applied Biology, Inc. | Treatment of sexual dysfunction |
-
2015
- 2015-11-13 BR BR112017009980A patent/BR112017009980A2/pt not_active Application Discontinuation
- 2015-11-13 CA CA2967375A patent/CA2967375C/en active Active
- 2015-11-13 CN CN201580073484.5A patent/CN107427479B/zh active Active
- 2015-11-13 KR KR1020177016144A patent/KR102476626B1/ko active Active
- 2015-11-13 JP JP2017526595A patent/JP6829196B2/ja not_active Expired - Fee Related
- 2015-11-13 US US15/524,012 patent/US10238593B2/en not_active Expired - Fee Related
- 2015-11-13 AU AU2015346126A patent/AU2015346126B2/en active Active
- 2015-11-13 WO PCT/US2015/060663 patent/WO2016077744A1/en not_active Ceased
- 2015-11-13 ES ES15858397T patent/ES2761688T3/es active Active
- 2015-11-13 EP EP15858397.1A patent/EP3217967B1/en active Active
- 2015-11-13 NZ NZ731850A patent/NZ731850A/en unknown
-
2016
- 2016-11-17 US US15/354,743 patent/US20170135988A1/en not_active Abandoned
-
2020
- 2020-10-23 JP JP2020177785A patent/JP7213216B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20170098825A (ko) | 2017-08-30 |
| US20170333316A1 (en) | 2017-11-23 |
| EP3217967A4 (en) | 2018-08-15 |
| US10238593B2 (en) | 2019-03-26 |
| AU2015346126A1 (en) | 2017-06-01 |
| JP6829196B2 (ja) | 2021-02-10 |
| CN107427479A (zh) | 2017-12-01 |
| HK1247560A1 (zh) | 2018-09-28 |
| CA2967375C (en) | 2023-08-15 |
| CN107427479B (zh) | 2021-03-30 |
| US20170135988A1 (en) | 2017-05-18 |
| JP2017533953A (ja) | 2017-11-16 |
| ES2761688T3 (es) | 2020-05-20 |
| EP3217967B1 (en) | 2019-09-18 |
| KR102476626B1 (ko) | 2022-12-09 |
| AU2015346126B2 (en) | 2020-07-30 |
| BR112017009980A2 (pt) | 2018-02-14 |
| CA2967375A1 (en) | 2016-05-19 |
| EP3217967A1 (en) | 2017-09-20 |
| WO2016077744A1 (en) | 2016-05-19 |
| JP7213216B2 (ja) | 2023-01-26 |
| JP2021020938A (ja) | 2021-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112017009980A2 (pt) | ?sistema e método para prevenção de alopecia?. | |
| MX2019015578A (es) | Metodos para tratar la enfermedad de huntington. | |
| MX2019015580A (es) | Metodos para tratar la enfermedad de huntington. | |
| MX389228B (es) | Composiciones para tratar el cabello. | |
| SG10201810888XA (en) | Compositions and methods comprising bupropion or related compounds and dextromethorphan | |
| WO2017062835A3 (en) | Compositions and methods for treating duchenne muscular dystrophy and related disorders | |
| MX2017010544A (es) | Metodos y composiciones para tratar la enfermedad del ojo seco y otros trastornos del ojo. | |
| EP4324845A3 (en) | Methods and pharmaceutical composition for the treatment and the prevention of cardiomyopathy due to energy failure | |
| SG10201808661XA (en) | Method of treating obesity using antioxidant inflammation modulators | |
| MX2018002344A (es) | Metodo para tratar el cancer. | |
| ZA202104737B (en) | Methods and compositions for treating skin and hair disorders | |
| BR112017026535A2 (pt) | composto de fórmula estrutural i, enantiômero isolado, composição farmacêutica, método para inibir atividade do transportador de monocarboxilato mct4, método para inibir seletivamente atividade do transportador de monocarboxilato mct4, método para tratar um distúrbio mediado por transportador de monocarboxilato mct4 e uso de um composto | |
| SA113340494B1 (ar) | تركيبة لعلاج اضطرابات أيضية | |
| NZ744323A (en) | Compositions comprising 15-hepe and methods of using the same | |
| IL304273A (en) | Compositions and methods for treating Fabry disease | |
| BR112017019971A2 (pt) | exclusão de éxon induzida por anti-sentido em miostatina | |
| MX2017015012A (es) | Formulaciones tópicas y orales que comprenden taurina y magnesio para la prevención y el tratamiento del acné. | |
| MX2014005404A (es) | Composicion cosmetica. | |
| IN2014DE01913A (cg-RX-API-DMAC7.html) | ||
| IL279208A (en) | Therapeutic methods and compositions for the treatment of pancreatic cancer using 6, 8-bis(benzylsulfenyl)octanoic acid | |
| WO2016168553A8 (en) | Deuterated obeticholic acid | |
| SI3348547T1 (sl) | Derivati benzimidazola kot zaviralci NAV 1.7 (natrijevi kanalčki, napetostno odvisni, tip IX, podenota alfa (SCN9A)) za zdravljenje bolečine, disurije in multiple skleroze | |
| HK1247136A1 (zh) | 包含15-hepe的组合物和其使用方法 | |
| MX2025015454A (es) | Formulaciones/composiciones que comprenden ibrutinib | |
| MX2019007041A (es) | Metodos y composiciones para tratar la enfermedad de parkinson. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 13 NOV 2025 BY AJ PARK Effective date: 20241017 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 13 NOV 2026 BY AJ PARK Effective date: 20250917 |